Effect of patient education on medication adherence of patients with rheumatoid arthritis: A randomized controlled trial

Patient Preference and Adherence

Volumn 13, Issue , 2019, Pages 119-129

  Taibanguay, Nichapa ^a   Chaiamnuay, Sumapa ^a   Asavatanabodee, Paijit ^a   Narongroeknawin, Pongthorn ^a  

^a PHRAMONGKUTKLAO HOSPITAL   (Thailand)

Author keywords

Adherence; Disease pamphlet; Education; Rheumatoid arthritis

Indexed keywords

CHLOROQUINE; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CLINICAL OUTCOME; CONTROLLED STUDY; DAS28; EUROPEAN QUALITY OF LIFE 5 DIMENSIONS QUESTIONNAIRE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MEDICATION TAKING BEHAVIOR; PAIN ASSESSMENT; PATIENT EDUCATION; PHYSICIAN GLOBAL ASSESSMENT; PILL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; THAI (PEOPLE); THAILAND; VISUAL ANALOG SCALE;

EID: 85070219840     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S192008     Document Type: Article

References (67)

1. Harris ED. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med. 1990;322(18):1277–1289.
2. Erickson AR, Cannella AC, Mikuls TR. Clinical Features of Rheumatoid Arthritis. In: Firestein GS, Budd RC, Gabriel SE, McInnes IB, O’Dell JR, editors. Kelley and Firestein’s Textbook of Rheumatology. 10 ed. Philadelphia: Elservier, Inc.; 2016:1167–1168.
3. Chaiamnuay P, Darmawan J, Muirden KD, Assawatanabodee P. Epidemiology of rheumatic disease in rural Thailand: a WHO-ILAR COPCORD study. Community oriented programme for the control of rheumatic disease. J Rheumatol. 1998;25(7):1382–1387.
4. Louthrenoo W. An insight into rheumatology in Thailand. Nat Rev Rheumatol. 2015;11(1):55–61.
5. Osiri M, Maetzel A, Tugwell P. The economic burden of rheumatoid arthritis in a developing nation: results from a one-year prospective cohort study in Thailand. J Rheumatol. 2007;34(1):57–63.
6. Xia Y, Yin R, Fu T, et al. Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis. Patient Prefer Adherence. 2016;10:735–742.
7. Prudente LR, Diniz JS, Ferreira TX, et al. Medication adherence in patients in treatment for rheumatoid arthritis and systemic lupus erythe-matosus in a university hospital in Brazil. Patient Prefer Adherence. 2016; 10:863–870.
8. Kumar K, Raza K, Nightingale P, et al. Determinants of adherence to disease modifying anti-rheumatic drugs in White British and South Asian patients with rheumatoid arthritis: a cross sectional study. BMC Musculoskelet Disord. 2015;16(1):396.
9. van den Bemt BJ, den Broeder AA, van den Hoogen FH, et al. Making the rheumatologist aware of patients’ non-adherence does not improve medication adherence in patients with rheumatoid arthritis. Scand J Rheumatol. 2011;40(3):192–196.
10. Scheiman-Elazary A, Duan L, Shourt C, et al. The rate of adherence to antiarthritis medications and associated factors among patients with rheumatoid arthritis: a systematic literature review and metaanalysis. J Rheumatol. 2016;43(3):512–523.
11. Wong PK. Medication adherence in patients with rheumatoid arthritis: why do patients not take what we prescribe? Rheumatol Int. 2016; 36(11):1535–1542.
12. De Vera MA, Mailman J, Galo JS. Economics of non-adherence to biologic therapies in rheumatoid arthritis. Curr Rheumatol Rep. 2014; 16(11):460.
13. Hovstadius B, Petersson G. Non-adherence to drug therapy and drug acquisition costs in a national population – a patient-based register study. BMC Health Serv Res. 2011;11(1):326.
14. Pascual-Ramos V, Contreras-Yáñez I, Villa AR, Cabiedes J, Rull-Gabayet M. Medication persistence over 2 years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and with disability. Arthritis Res Ther. 2009; 11(1):R26.
15. Brandstetter S, Riedelbeck G, Steinmann M, Loss J, Ehrenstein B, Apfelbacher C. Depression moderates the associations between beliefs about medicines and medication adherence in patients with rheumatoid arthritis: Cross-sectional study. J Health Psychol. 2018;23(9):1185–1195.
16. Harnett J, Wiederkehr D, Gerber R, Gruben D, Bourret J, Koenig A. Primary nonadherence, associated clinical outcomes, and health care resource use among patients with rheumatoid arthritis prescribed treatment with injectable biologic disease-modifying antirheumatic drugs. J Manag Care Spec Pharm. 2016;22(3):209–218.
17. Harrold LR, Briesacher BA, Peterson DAN, et al. Cost-related medication nonadherence in older patients with rheumatoid arthritis. J Rheumatol. 2013;40(2):137–143.
18. Joplin S, van der Zwan R, Joshua F, Wong PK. Medication adherence in patients with rheumatoid arthritis: the effect of patient education, health literacy, and musculoskeletal ultrasound. BioMed Res Int. 2015; 2015:150658.
19. Li L, Cui Y, Yin R, et al. Medication adherence has an impact on disease activity in rheumatoid arthritis: a systematic review and meta-analysis. Patient Prefer Adherence. 2017;11:1343–1356.
20. Morgan C, McBeth J, Cordingley L, et al. The influence of behavioural and psychological factors on medication adherence over time in rheumatoid arthritis patients: a study in the biologics era. Rheumatology. 2015;54(10):1780–1791.
21. Rauscher V, Englbrecht M, van der Heijde D, Schett G, Hueber AJ. High degree of nonadherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. J Rheumatol. 2015;42(3): 386–390.
22. Salt E, Frazier SK. Predictors of medication adherence in patients with rheumatoid arthritis. Drug Dev Res. 2011;72(8):756–763.
23. Salt E, Hall L, Peden AR, Home R. Psychometric properties of three medication adherence scales in patients with rheumatoid arthritis. J Nurs Meas. 2012;20(1):59–72.
24. Santoleri F, Sorice P, Lasala R, Rizzo RC, Costantini A. Medication adherence and persistence in the treatment of rheumatoid arthritis with adalimumab and etanercept. Six years of analysis. J Med Econ. 2014; 17(5):320–325.
25. Shetty R, Reddy K, Inam S, Khera K. Impact of medication adherence by using Indian version compliance questionnaire rheumatology (Cqr) and medication adherence report scale (Mars) tools on quality of life of patients with rheumatoid arthritis. Value Health. 2014;17(7):A385.
26. Spruill TM, Ogedegbe G, Harrold LR, et al. Association of medication beliefs and self-efficacy with adherence in urban Hispanic and African-American rheumatoid arthritis patients. Ann Rheum Dis. 2014; 73(1):317–318.
27. Suh YS, Cheon YH, Kim HO, et al. Medication nonadherence in Korean patients with rheumatoid arthritis: the importance of belief about medication and illness perception. The Korean J Intern Med. 2018; 33(1):203–210.
28. Treharne GJ, Lyons AC, Hale ED, Douglas KM, Kitas GD. Predictors of medication adherence in people with rheumatoid arthritis: studies are necessary but non-validated measures of medication adherence are of concern. Rheumatology (Oxford). 2005;44(10):1330.
29. Tuncay R, Eksioglu E, Cakir B, Gurcay E, Cakci A. Factors affecting drug treatment compliance in patients with rheumatoid arthritis. Rheumatol Int. 2007;27(8):743–746.
30. van den Bemt BJ, van den Hoogen FH, Benraad B, Hekster YA, van Riel PL, van Lankveld W. Adherence rates and associations with non-adherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs. J Rheumatol. 2009;36(10):2164–2170.
31. van den Bemt BJ, Zwikker HE, van den Ende CH. Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Expert Rev Clin Immunol. 2012;8(4):337–351.
32. Viller F, Guillemin F, Briancon S, Moum T, Suurmeijer T, van den Heuvel W. Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study. J Rheumatol. 1999;26(10): 2114–2122.
33. Zwikker HE, van Dulmen S, den Broeder AA, van den Bemt BJ, van den Ende CH. Perceived need to take medication is associated with medication non-adherence in patients with rheumatoid arthritis. Patient Prefer Adherence. 2014;8:1635–1645.
34. Bruera S, Barbo AG, Lopez-Olivo MA. Use of medication reminders in patients with rheumatoid arthritis. Rheumatol Int. 2016;36(11): 1543–1548.
35. Barton JL, Trupin L, Schillinger D, et al. Use of low-literacy decision aid to enhance knowledge and reduce decisional conflict among a diverse population of adults with rheumatoid arthritis: results of a pilot study. Arthritis Care Res. 2016;68(7):889–898.
36. Depont F, Berenbaum F, Filippi J, et al. Interventions to improve adherence in patients with immune-mediated inflammatory disorders: a systematic review. PLoS One. 2015;10(12):e0145076.
37. Hill J, Bird H, Johnson S. Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial. Ann Rheum Dis. 2001;60(9):869–875.
38. Evers AW, Kraaimaat FW, van Riel PL, de Jong AJ. Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial. Pain. 2002;100(1–2):141–153.
39. El Miedany Y, El Gaafary M, Palmer D. Assessment of the utility of visual feedback in the treatment of early rheumatoid arthritis patients: a pilot study. Rheumatol Int. 2012;32(10):3061–3068.
40. El Miedany Y, El Gaafary M, El Arousy N, Ahmed I, Youssef S, Palmer D. Arthritis education: the integration of patient-reported outcome measures and patient self-management. Clin Exp Rheumatol. 2012;30(6):899–904.
41. Homer D, Nightingale P, Jobanputra P. Providing patients with information about disease-modifying anti-rheumatic drugs: individually or in groups? A pilot randomized controlled trial comparing adherence and satisfaction. Musculoskeletal Care. 2009;7(2):78–92.
42. Brus HL, van de Laar MA, Taal E, Rasker JJ, Wiegman O. Effects of patient education on compliance with basic treatment regimens and health in recent onset active rheumatoid arthritis. Ann Rheum Dis. 1998;57(3):146–151.
43. Greenley RN, Kunz JH, Walter J, Hommel KA. Practical strategies for enhancing adherence to treatment regimen in inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(7):1534–1545.
44. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998;36(8):1138–1161.
45. National Collaborating Centre for Primary Care. Medicines Adherence: Involving Patients in Decisions About Prescribed Medicines and Supporting Adherence; 2009. Available from: https://www.nice.org.uk/guidance/cg76. Accessed October 25, 2018.
46. Sakthong P, Sonsa-Ardjit N, Sukarnjanaset P, Munpan W, Suksanga P. Development and psychometric testing of the medication taking behavior tool in Thai patients. Int J Clin Pharm. 2016;38(2):438–445.
47. Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–1736.
48. Prevoo MLL, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LBA, van Riel PLCM. Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44–48.
49. Nilchaikovit T, Lotrakul M, Phisansuthideth U. Development of Thai version of hospital anxiety and depression scale in cancer patients. J Psychiatr Assoc Thailand. 1996;41(1):18–30.
50. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370.
51. Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631–637.
52. Sowattanangoon N. Brief Illness Perception Scale (Thai version); 2008. Available from: http://www.uib.no/ipq/html/b-ipq.html. Accessed October 25, 2018.
53. Tangwongchai S, Phanasathit M, Charernboon T, et al. The validity of Thai version of the Montreal Cognitive Assessment (MoCA-T). Dement Neuropsychol. 2009;3(2):172. Available from: http://demneu-ropsy.com.br/imageBank/pdf/dnv03n02a11.pdf. Accessed January 3, 2019.
54. Train The Brain Forum Committee. Thai Mental State Examination (TMSE). Siriraj Med J. 1993;45(6):1695–1703.
55. Ngamjarus C. n4Studies: Sample Size Calculation for an Epidemio-logical Study on a Smart Device. Siriraj Med J. 2016;68(3):160–170.
56. Moshkovska T, Stone MA, Smith RM, Bankart J, Baker R, Mayberry JF. Impact of a tailored patient preference intervention in adherence to 5-aminosalicylic acid medication in ulcerative colitis: results from an exploratory randomized controlled trial. Inflamm Bowel Dis. 2011;17(9): 1874–1881.
57. Cook PF, Emiliozzi S, El-Hajj D, McCabe MM. Telephone nurse counseling for medication adherence in ulcerative colitis: a preliminary study. Patient Educ Couns. 2010;81(2):182–186.
58. Elkjaer M, Shuhaibar M, Burisch J, et al. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ‘constant-care’ approach. Gut. 2010;59(12):1652–1661.
59. Moss AC, Chaudhary N, Tukey M, et al. Impact of a patient-support program on mesalamine adherence in patients with ulcerative colitis – a prospective study. J Crohns Colitis. 2010;4(2):171–175.
60. Zwikker HE, van den Ende CH, van Lankveld WG, et al. Effectiveness of a group-based intervention to change medication beliefs and improve medication adherence in patients with rheumatoid arthritis: a randomized controlled trial. Patient Educ Couns. 2014;94(3):356–361.
61. Treharne GJ, Lyons AC, Hale ED, Douglas KM, Kitas GD. ‘Compliance’ is futile but is ‘concordance’ between rheumatology patients and health professionals attainable? Rheumatology. 2006;45(1):1–5.
62. Peveler R, George C, Kinmonth AL, Campbell M, Thompson C. Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. BMJ. 1999;319(7210):612–615.
63. Helliwell PS, O’Hara M, Holdsworth J, Hesselden A, King T, Evans P. A 12-month randomized controlled trial of patient education on radiographic changes and quality of life in early rheumatoid arthritis. Rheumatology. 1999;38(4):303–308.
64. Dunbar J, Dunning EJ, Dwyer K. Compliance measurement with arthritis regimen. Arthritis Care Res. 1989;2(3):A8–A16.
65. Pullar T. Compliance with drug therapy. Br J Clin Pharmacol. 1991; 32(5):535–539.
66. Miles S, Davis T. Patients who can’t read. Implications for the health care system. JAMA. 1995;274(21):1719–1720.
67. Health literacy: report of the Council on Scientific Affairs. Ad Hoc Committee on Health Literacy for the Council on Scientific Affairs, American Medical Association. JAMA. 1999;281(6):552–557.